Privigen

CSL Behring AG🇺🇸 United States

FDA Page

Effective Date: May 4, 2026
Approval ID: 7e5649da-75be-4a42-8eeb-4aeba562c401
Products: 4 registered
Version: 29

Regulatory Information

Labeling Type

PLASMA DERIVATIVE

Status

Approved

Full Title

These highlights do not include all the information needed to use PRIVIGEN safely and effectively. See full prescribing information for PRIVIGEN. PRIVIGEN, Immune Globulin Intravenous (Human), 10% Liquid, for intravenous use Initial U.S. Approval: 2007

Quick Stats

Total Products4

Labelers1

Label Sections39

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.